AKC Canine Health Foundation Canine Cancer Research
Since 1995, CHF and its donors have funded over $17.7 million in canine cancer research. These 263 research grants have helped scientists study cancer at the cellular level, providing breakthroughs that allow veterinarians to diagnose cancer earlier and treat it more effectively. CHF-funded research also has a One Health impact, extending beyond dogs with an application to human cancer diagnosis and treatment.
Canine cancer research is a major concern of dog owners and veterinary professionals. Typically, about one quarter of CHF’s grant funding concerns various types of canine cancers.
View our Cancer Research Portfolio
Canine Cancer Articles
Promising Drug Treatment for Brain Tumors September 10, 2021
A novel drug that activates programmed cell death in many cancer cells was well tolerated in dogs and may be effective against meningioma – cancer of the membrane surrounding the brain and spinal cord.
AKC Canine Health Foundation Marks Pet Cancer Awareness Month with Over $850,000 in Newly Awarded Cancer Grants May 3, 2021
CHF marks Pet Cancer Awareness Month this May with over $850,000 invested in eleven newly awarded canine cancer research grants.
Promising Research on the Use of CBD to Treat Canine Cancer March 22, 2021
A CHF-funded study documents the anti-cancer effects of CBD alone and in combination with chemotherapy drugs.
Liquid Biopsy for Canine Histiocytic Sarcoma and Lymphoma March 16, 2021
Liquid biopsy through measurement of circulating tumor DNA in a blood sample shows promise in diagnosing canine cancers such as histiocytic sarcoma and multicentric lymphoma.
A One Health Approach to Beating Cancer August 27, 2020
Recent discoveries by AKC Canine Health Foundation funded researchers demonstrate the power of a One Health approach in fighting cancer, a devastating disease found in humans and dogs.
The AKC Canine Health Foundation celebrates their 2019 Canine Cancer Research Initiative matched by the American Kennel Club and announces a new match challenge for canine hemangiosarcoma research.
American German Shepherd Dog Charitable Foundation and AKC Canine Health Foundation Join Efforts for Canine Hemangiosarcoma Research December 21, 2018
The AKC Canine Health Foundation (CHF), working alongside the American German Shepherd Dog Charitable Foundation (AGSDCF), offers a new matched funding opportunity for their Hemangiosarcoma Research Initiative. The AGSDCF will match donations to hemangiosarcoma research up to $33,500 as part of a three-year pledge to fight this devastating canine cancer.
Flat-Coated Retriever Foundation and Golden Retriever Foundation Add Matching Funds for Canine Hemangiosarcoma Research September 19, 2018
The AKC Canine Health Foundation (CHF) has extended their matched funding opportunity for the 2018 Hemangiosarcoma Research Initiative with a gift from the Flat-Coated Retriever Foundation.
The AKC Canine Health Foundation (CHF) announces an ongoing matched funding opportunity for their Hemangiosarcoma Research Initiative.
Reevaluating the Nature of Hemangiosarcoma April 24, 2015
Hemangiosarcoma is a type of cancer that is quite common in dogs. It is aggressive and deadly; more than 50% of dogs with hemangiosarcoma die within four to six months of diagnosis. But thanks to you, two exciting, new studies from researchers at the University of Minnesota, Twin Cities have begun to shed new light on where these tumors come from and how they grow.
Resources Available for Download
Cancer Attributable to Infection?
Original air date: June 8, 2022
Speaker: Edward B. Breitschwerdt, DVM, DACVIM
May 2022 Canine Cancer Webinar Series
Available on a pay per view basis through the AKC Canine College.
Predicting Lymphoma in Dogs, Presented by Dr. Daniel Promislow
Luteinizing Hormone Receptor Activation in Lymphoma and Hemangiosarcoma, Presented by Dr. Michelle Kutzler
Toward Curative Outcomes in Canine Hemangiosarcoma, Presented by Dr. Chand Khanna
LIVE Panel Q&A Session, Presented by Drs. Promislow, Kutzler, and Khanna
A Novel Non-Surgical Option to Preserve Limbs in Canine Osteosarcoma
Original air date: May 25, 2021
Speaker: Joanne Tuohy, DVM, PhD, DACVS
Recent Advances in Cancer Immunotherapy
Original air date: May 2020
Speaker: Steven Dow, DVM, PhD, Diplomate ACVIM (Oncology)
Update on Canine Hemangiosarcoma
Original air date: May 2017
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Cancer Immunotherapy: Basic Concepts and Strategies for Improving Treatment Outcomes
Original air date: October 2016
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Lymphoma: The State of This Disease in Dogs and How Epigenetics May Open Future Doors
Original air date: June 2016
Speaker: Jeffrey M. Bryan, DVM, MS, PhD, DACVIM (Oncology)
Tracie Hotchner Pets podcast spoke with CHF Board Chairman, Dr. Charles Garvin, about CHF-funded grants studying innovative new ways to detect and treat cancer.
The Dog Cancer Answers podcast spoke with AKC Chief Veterinary Officer Dr. Jerry Klein about How to Choose a Dog Breeder. Listen for ways to increase the odds of having a healthy puppy, including the importance of AKC Canine Health Foundation funded research.
How You Can Help
Your support means more studies exploring improved diagnostics and new treatment strategies for canine cancer.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.